The Future of Life-saving Treatments
We reduce the world's organ shortage and speed up drug development by providing life science solutions that combine biology and technology.
Interim Report
January – March 2022
Continued growth in sales, improved profitability and focus on commercial synergies.
Printing the Future of Health
Our revolutionary bioprinting workflows are enabling the future of health through bioprinting of tissues and organs. Together with our new automation software from Biosero, we will enhance the user experience and speed up research and development around the world.
Bico by numbers
press releases
05/18/22RegulatoryBICO Publishes Interim Report January – March 2022: Continued growth in sales, improved profitability and focus on commercial synergies
05/02/22RegulatoryBusiness update for BICO Group AB (publ)
04/29/22New Interim CFO at BICO
04/27/22BICO's Board of Directors: "Full confidence in the CEO, management and current strategic direction"
04/26/22RegulatoryBulletin from Annual General Meeting in BICO Group AB (publ)
04/26/22RegulatoryBICO's CFO Gusten Danielsson leaves his assignment
03/24/22RegulatoryNotice to Attend the Annual General Meeting in BICO Group AB (Publ)
03/16/22RegulatoryBICO publishes Annual Report 2021
02/28/22RegulatoryBICO Group AB (publ) announces an increase in number of shares and votes
02/23/22RegulatoryYear-end report 2021: Strong growth, positive EBITDA, and a clear plan for increased profitability
01/31/22RegulatoryBICO Group AB (publ) announces an increase in number of shares and votes
01/13/22BICO Partners with the Center for Contemporary Sciences to Reduce Animal Testing in Life Sciences
12/16/21RegulatoryBICO has entered into an agreement to acquire Biosero, a leading software provider for automated workflows and laboratory connectivity
12/10/21BICO’s CELLINK Bioprinters Used by CTIBIOTECH to Produce World’s First Immunized Human Skin Model
12/09/21BICO and Nanochon Announce Commercial Agreement to Develop 3D Printed Joint Restoration Implant
12/08/21BICO wins SwedenBIO Award 2021
11/17/21RegulatoryBulletin from the extraordinary general meeting in BICO Group AB (publ)
Products
We’re equipping hundreds of labs with technologies that fuel groundbreaking scientific breakthroughs. Explore a selection of products within BICO.
BICO News Feed
Discover the latest news from our business areas.
May 24, 2022
Bico Biosero, a Part of BICO Biosciences Is Awarded a New Patent for Laboratory Automation Scheduling Software
Bico Biosero, a Part of BICO Biosciences Is Awarded a New Patent for Laboratory Automation Scheduling Software
May 24, 2022
Cellenion Breakfast with Cellenion
Cellenion Breakfast with Cellenion
May 16, 2022
Bico BICO joins The North American 3Rs Collaborative’s (NA3RsC) Microphysiological Systems (MPS) Initiative
Bico BICO joins The North American 3Rs Collaborative’s (NA3RsC) Microphysiological Systems (MPS) Initiative
May 11, 2022
Dispendix SLAS Europe 2022 – Dublin
Dispendix SLAS Europe 2022 – Dublin
FINANCIAL REPORTS
Calendar
05/18/22Interim report January-March 2022
08/24/22Interim report January-June 2022
11/09/22Interim report January-September 2022
02/22/23Year-end report 2022
BICO in the press
02/18/22 Technology Networks3D Bioprinting Set To Propel Medical Research Forward
12/28/21 3DPrint.com2022 Predictions: Bioprinting Leaders Weigh in
12/20/21 ForbesOp-Ed: The FDA Modernization Act Can Leverage Technology To Accelerate Drug Discovery And Save Millions Of Animals
12/17/21 Genetic Engineering & Biotechnology NewsBICO Group Expands into Software with Up-to-$165M Biosero Acquisition
12/16/21 San Diego Union TribuneSan Diego’s Biosero acquired by Swedish life sciences tech firm for $165 million
12/16/21 3D Printing Media NetworkBICO Endorses FDA Modernization Act of 2021
12/15/21 3D Printing IndustryCELLINK And Nanoscribe Announce New Jointly-Developed Quantum X Bio 3D Printer
12/14/21 3DPrint.comBICO Announces Million-Dollar Contract for 3D Printed Joint Implants
12/07/21 Drug Discovery & DevelopmentCYTENA Inks $10M Deal to Distribute its Single-Cell Isolators in China
11/26/21 Nordic Life Science NewsThese are the 5 nominees for the SwedenBIO Award
11/18/21 PharmTechFocusBICO Announces Appointment of Susan Tousi as New Member of the Board of Directors
11/16/21 GenomeWebBruker, Cellenion Ink Comarketing Agreement for Single-Cell Proteomics
11/15/21 GenomeWebThermo Fisher Scientific, Cellenion Partner to Develop Workflows for Single-Cell Proteomics Analysis
11/10/21 GenomeWebCellenion Expands Automated Cell Sorting Market, Targets Spheroids
10/22/21 Life Science SwedenBICO Awarded the Export Success of the Year
10/19/21 Mass DeviceBICO’s Cytena launches C.Station automated cell line development platform for antibody and gene therapies
10/14/21 3D Printing Media NetworkBICO grows IP portfolio with patents in the United States and Sweden
10/07/21 BioSpaceBICO Group Acquires QInstruments
09/22/21 3D Printing Media NetworkCELLINK, MatTek and Visikol launch 3D Bioprinting CRO
09/20/21 3DPrint.comNanoscribe’s New Microfabrication 3D Printer Makes Complex Structures for Life Sciences
09/17/21 3D Printing IndustryNanoscribe Launches the Quantum X Shape 3D Printer
09/01/21 Genetic Engineering & Biotechnology NewsBuying Spree: Rebranded BICO Bets Big on “Bioconvergence”
08/31/21 San Diego Business JournalAdvanced BioMatrix Acquired by BICO for $15M
08/27/21 AIThorityBICO has Acquired Advanced BioMatrix, an Innovative Company focused on 3D Applications
08/26/21 GenomeWebScienion, Cellenion Enter Exclusive Licensing Deal, Partnership With Pacific Northwest National Lab
08/20/21 Nordic Life Science NewsCELLINK rebrands itself to BICO
08/19/21 3D Printing IndustryCELLINK Parent Firm Rebranded BICO, Reports Over 600% Acquisition-Led Growth in H1 2021
08/18/21 Boston Business JournalBioprinting startup restructures on the verge of 'bioconvergence revolution'
We are BICO
We extend the boundaries of what’s possible to give people better and healthier lives.
We are BICO
